Larry J. Copeland

Oncology

3691 Ridge Mill Dr
Hilliard, OH 43026

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 02, 2026

Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer.

Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer.

Journal: Gynecologic oncology reports

Published: June 14, 2026

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Journal: Gynecologic oncology

Published: June 12, 2026

Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.

Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.

Journal: Gynecologic oncology

Published: May 29, 2026

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 28, 2026

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 28, 2026

Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?

Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?

Journal: Gynecologic oncology

Published: April 14, 2026

Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma.

Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma.

Journal: Gynecologic oncology

Published: April 07, 2026

No time to waste: Evaluation of diagnostic delays in vulvar cancer.

No time to waste: Evaluation of diagnostic delays in vulvar cancer.

Journal: Gynecologic oncology

Published: April 05, 2026

Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility study.

Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility study.

Journal: Gynecologic oncology

Published: February 23, 2026

Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.

Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.

Journal: Gynecologic oncology

Published: January 19, 2026

Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026